Effects of brain-derived and glial cell line-derived neurotrophic factors on startle response and disrupted prepulse inhibition in mice of DBA/2J inbred strain

Neuroscience Letters

Volumn 550, Issue , 2013, Pages 115-118

  Naumenko, Vladimir S ^a   Bazovkina, Daria V ^a   Morozova, Maryana V ^a   Popova, Nina K ^a  

^a INSTITUTE OF CYTOLOGY AND GENETICS   (Russian Federation)

Author keywords

Brain derived neurotrophic factor; DBA 2J mice; Glial cell line derived neurotrophic factor; Prepulse inhibition; Startle response

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR;

ANIMAL EXPERIMENT; ARTICLE; EPIGENETICS; HABITUATION; MOUSE; NERVOUS SYSTEM DEVELOPMENT; NONHUMAN; PREPULSE INHIBITION; PRIORITY JOURNAL; SENSORY GATING; STARTLE REFLEX;

BRAIN-DERIVED NEUROTROPHIC FACTOR; DBA/2J MICE; GLIAL CELL LINE-DERIVED NEUROTROPHIC FACTOR; PREPULSE INHIBITION; STARTLE RESPONSE;

ANIMALS; BRAIN; BRAIN-DERIVED NEUROTROPHIC FACTOR; GLIAL CELL LINE-DERIVED NEUROTROPHIC FACTOR; MALE; MICE; MICE, INBRED DBA; NEURAL INHIBITION; SENSORY GATING; STARTLE REACTION;

EID: 84881371353     PISSN: 03043940     EISSN: 18727972     Source Type: Journal    
DOI: 10.1016/j.neulet.2013.06.056     Document Type: Article

References (34)

1. Bakshi V.P., Swerdlow N.R., Braff D.L., Geyer M.A. Reversal of isolation rearing-induced deficits in prepulse inhibition by Seroquel and olanzapine. Biol. Psychiatry 1998, 43:436-445.
2. Barde Y.A. The nerve growth factor family. Prog. Growth Factor Res. 1990, 2:237-248.
3. Boger H.A., Middaugh L.D., Huang P., Zaman V., Smith A.C., Hoffer B.J., Tomac A.C., Granholm A.C. A partial GDNF depletion leads to earlier age-related deterioration of motor function and tyrosine hydroxylase expression in the substantia nigra. Exp. Neurol. 2006, 202:336-347.
4. Cadenhead K.S., Geyer M.A., Braff D.L. Impaired startle prepulse inhibition and habituation in patients with schizotypal personality disorder. Am. J. Psychiatry 1993, 150:1862-1867.
5. Carlino D., De Vanna M., Tongiorgi E. Is altered BDNF biosynthesis a general feature in patients with cognitive dysfunctions?. Neuroscientist 2013, 19:345-353.
6. De Carolis L., Stasi M.A., Serlupi-Crescenzi O., Borsini F., Nencini P. The effects of clozapine on quinpirole-induced non-regulatory drinking and prepulse inhibition disruption in rats. Psychopharmacology (Berl) 2010, 212:105-115.
7. Dulawa S.C., Hen R., Scearce-Levie K., Geyer M.A. Serotonin1B receptor modulation of startle reactivity, habituation, and prepulse inhibition in wild-type and serotonin1B knockout mice. Psychopharmacology (Berl) 1997, 132:125-134.
8. Geyer M.A., Swerdlow N.R., Mansbach R.S., Braff D.L. Startle response models of sensorimotor gating and habituation deficits in schizophrenia. Brain Res. Bull. 1990, 25:485-498.
9. Gogos A., van den Buuse M. The importance of baseline in identifying 8-OH-DPAT-induced effects on prepulse inhibition in rats. Br. J. Pharmacol. 2007, 150:750-757.
10. Hoffman H.S., Ison J.R. Reflex modification in the domain of startle. I. Some empirical findings and their implications for how the nervous system processes sensory input. Psychol. Rev. 1980, 87:175-189.
11. Hu Y., Russek S.J. BDNF and the diseased nervous system: a delicate balance between adaptive and pathological processes of gene regulation. J. Neurochem. 2008, 105:1-17.
12. Jensen K.S., Oranje B., Wienberg M., Glenthoj B.Y. The effects of increased central serotonergic activity on prepulse inhibition and habituation of the human startle response. Neuropsychopharmacology 2007, 32:2117-2124.
13. Lapchak P.A., Miller P.J., Jiao S. Glial cell line-derived neurotrophic factor induces the dopaminergic and cholinergic phenotype and increases locomotor activity in aged Fischer 344 rats. Neuroscience 1997, 77:745-752.
14. Lau B.W., Yau S.Y., Lee T.M., Ching Y.P., Tang S.W., So K.F. Intracerebroventricular infusion of cytosine-arabinoside causes prepulse inhibition disruption. Neuroreport 2009, 20:371-377.
15. Light G.A., Braff D.L. Human and animal studies of schizophrenia-related gating deficits. Curr. Psychiatry Rep. 1999, 1:31-40.
16. Ludewig K., Geyer M.A., Vollenweider F.X. Deficits in prepulse inhibition and habituation in never-medicated, first-episode schizophrenia. Biol. Psychiatry 2003, 54:121-128.
17. Martin S., Lawrence A.J., van den Buuse M. Prepulse inhibition in fawn-hooded rats: increased sensitivity to 5-HT1A receptor stimulation. Eur. Neuropsychopharmacol. 2004, 14:373-379.
18. Mehta V., Hong M., Spears J., Mendez I. Enhancement of graft survival and sensorimotor behavioral recovery in rats undergoing transplantation with dopaminergic cells exposed to glial cell line-derived neurotrophic factor. J. Neurosurg. 1998, 88:1088-1095.
19. Michelato A., Bonvicini C., Ventriglia M., Scassellati C., Randazzo R., Bignotti S., Beneduce R., Riva M.A., Gennarelli M. 3' UTR (AGG)n repeat of glial cell line-derived neurotrophic factor (GDNF) gene polymorphism in schizophrenia. Neurosci. Lett. 2004, 357:235-237.
20. Naumenko V.S., Kondaurova E.M., Bazovkina D.V., Tsybko A.S., Tikhonova M.A., Kulikov A.V., Popova N.K. Effect of brain-derived neurotrophic factor on behavior and key members of the brain serotonin system in genetically predisposed to behavioral disorders mouse strains. Neuroscience 2012, 214:59-67.
21. Olivier B., Leahy C., Mullen T., Paylor R., Groppi V.E., Sarnyai Z., Brunner D. The DBA/2J strain and prepulse inhibition of startle: a model system to test antipsychotics?. Psychopharmacology (Berl) 2001, 156:284-290.
22. Papaleo F., Silverman J.L., Aney J., Tian Q., Barkan C.L., Chadman K.K., Crawley J.N. Working memory deficits, increased anxiety-like traits, and seizure susceptibility in BDNF overexpressing mice. Learn. Mem. 2011, 18:534-544.
23. Paylor R., Crawley J.N. Inbred strain differences in prepulse inhibition of the mouse startle response. Psychopharmacology (Berl) 1997, 132:169-180.
24. Pittenger C., Duman R.S. Stress, depression, and neuroplasticity: a convergence of mechanisms. Neuropsychopharmacology 2008, 33:88-109.
25. Popova N.K., Naumenko V.S., Tibeikina M.A., Kulikov A.V. Serotonin transporter, 5-HT1A receptor, and behavior in DBA/2J mice in comparison with four inbred mouse strains. J. Neurosci. Res. 2009, 87:3649-3657.
26. Schmidt H.D., Banasr M., Duman R.S. Future antidepressant targets: neurotrophic factors and related signaling cascades. Drug Discov. Today Ther. Strateg. 2008, 5:151-156.
27. Simosky J.K., Stevens K.E., Kem W.R., Freedman R. Intragastric DMXB-A, an alpha7 nicotinic agonist, improves deficient sensory inhibition in DBA/2 mice. Biol. Psychiatry 2001, 50:493-500.
28. Slotnick B.M., Leonard C.M. A Stereotaxic Atlas of the Albino Mouse Forebrain 1975, U.S. Dept. of Health, Education and Welfare, Rockville, Maryland.
29. Swerdlow N.R., Benbow C.H., Zisook S., Geyer M.A., Braff D.L. A preliminary assessment of sensorimotor gating in patients with obsessive compulsive disorder. Biol. Psychiatry 1993, 33:298-301.
30. Swerdlow N.R., Braff D.L., Taaid N., Geyer M.A. Assessing the validity of an animal model of deficient sensorimotor gating in schizophrenic patients. Arch. Gen. Psychiatry 1994, 51:139-154.
31. Takahashi M., Kakita A., Futamura T., Watanabe Y., Mizuno M., Sakimura K., Castren E., Nabeshima T., Someya T., Nawa H. Sustained brain-derived neurotrophic factor up-regulation and sensorimotor gating abnormality induced by postnatal exposure to phencyclidine: comparison with adult treatment. J. Neurochem. 2006, 99:770-780.
32. Taylor M.K., Ison J.R., Schwarzkopf S.B. Effects of single and repeated exposure to apomorphine on the acoustic startle reflex and its inhibition by a visual prepulse. Psychopharmacology (Berl) 1995, 120:117-127.
33. Tikhonova M., Kulikov A.V., Bazovkina D.V., Morozova M.V., Naumenko V.S., Popova N.K. Antidepressant-like effects of central BDNF administration in mice of antidepressant sensitive catalepsy (ASC) strain. Chin. J. Physiol. 2012, 55:284-293.
34. Zaman V., Li Z., Middaugh L., Ramamoorthy S., Rohrer B., Nelson M.E., Tomac A.C., Hoffer B.J., Gerhardt G.A., Granholm A. The noradrenergic system of aged GDNF heterozygous mice. Cell Transplant. 2003, 12:291-303.